ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,186,000 | +86.2% | 130,572 | 0.0% | 8.42% | +724.4% |
| Q2 2021 | $637,000 | +9.6% | 130,572 | 0.0% | 1.02% | +35.6% |
| Q1 2021 | $581,000 | +14.6% | 130,572 | 0.0% | 0.75% | +13.7% |
| Q4 2020 | $507,000 | +20.1% | 130,572 | 0.0% | 0.66% | -4.9% |
| Q3 2020 | $422,000 | -27.2% | 130,572 | 0.0% | 0.70% | +54.3% |
| Q2 2020 | $580,000 | +58.5% | 130,572 | +0.0% | 0.45% | +36.3% |
| Q1 2020 | $366,000 | -32.7% | 130,571 | 0.0% | 0.33% | -16.4% |
| Q4 2019 | $544,000 | +19.0% | 130,571 | 0.0% | 0.40% | +52.3% |
| Q3 2019 | $457,000 | -31.8% | 130,571 | 0.0% | 0.26% | -50.6% |
| Q2 2019 | $670,000 | -33.4% | 130,571 | -92.9% | 0.53% | -38.2% |
| Q1 2019 | $1,006,000 | +11.0% | 1,827,992 | 0.0% | 0.85% | -12.0% |
| Q4 2018 | $906,000 | -39.0% | 1,827,992 | 0.0% | 0.97% | +30.1% |
| Q3 2018 | $1,485,000 | -10.7% | 1,827,992 | 0.0% | 0.74% | -18.0% |
| Q2 2018 | $1,663,000 | -65.7% | 1,827,992 | 0.0% | 0.91% | -67.2% |
| Q1 2018 | $4,844,000 | -24.3% | 1,827,992 | 0.0% | 2.76% | -51.1% |
| Q4 2017 | $6,398,000 | -30.7% | 1,827,992 | 0.0% | 5.64% | -28.9% |
| Q3 2017 | $9,231,000 | +48.5% | 1,827,992 | 0.0% | 7.94% | +23.4% |
| Q2 2017 | $6,215,000 | -2.9% | 1,827,992 | 0.0% | 6.43% | -6.1% |
| Q1 2017 | $6,398,000 | +62.8% | 1,827,992 | 0.0% | 6.85% | +46.8% |
| Q4 2016 | $3,930,000 | -32.4% | 1,827,992 | 0.0% | 4.66% | -24.0% |
| Q3 2016 | $5,813,000 | +14.4% | 1,827,992 | 0.0% | 6.14% | +12.5% |
| Q2 2016 | $5,082,000 | -29.4% | 1,827,992 | 0.0% | 5.46% | -20.7% |
| Q1 2016 | $7,202,000 | -59.9% | 1,827,992 | 0.0% | 6.88% | -51.3% |
| Q4 2015 | $17,969,000 | -4.2% | 1,827,992 | 0.0% | 14.12% | +10.5% |
| Q3 2015 | $18,755,000 | -44.6% | 1,827,992 | 0.0% | 12.78% | -15.4% |
| Q2 2015 | $33,854,000 | – | 1,827,992 | – | 15.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|